Adam Kadlec
Directeur Général chez Rivermark Medical, Inc.
Profil
Adam Kadlec is currently the President, Chief Executive Officer & Director at Rivermark Medical, Inc. and an Advisor at Golden Angels Investors LLC since 2018.
He completed his undergraduate and graduate degrees at the University of Wisconsin.
Postes actifs de Adam Kadlec
Sociétés | Poste | Début |
---|---|---|
Golden Angels Investors LLC
Golden Angels Investors LLC Investment ManagersFinance Golden Angels Investors LLC (Golden Angels Investors) is a venture capital firm founded in 2002 by Timothy J Keane. The firm is headquartered in Brookfield, Wisconsin. | Consultant / Advisor | 01/04/2018 |
Rivermark Medical, Inc.
Rivermark Medical, Inc. Medical SpecialtiesHealth Technology The American company was founded by a practicing urologist with the aim of developing the preferred first-line device therapy for benign prostatic hyperplasia. The company's flagship product, the Flostent system, enables physicians to treat patients safely and efficiently, with minimal discomfort and reduced complications. Rivermark Medical plans to bring the Flostent system to market as their first product. The CEO of the company is Adam Kadlec. | Directeur Général | 01/08/2021 |
Formation de Adam Kadlec
University of Wisconsin | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Golden Angels Investors LLC
Golden Angels Investors LLC Investment ManagersFinance Golden Angels Investors LLC (Golden Angels Investors) is a venture capital firm founded in 2002 by Timothy J Keane. The firm is headquartered in Brookfield, Wisconsin. | Finance |
Rivermark Medical, Inc.
Rivermark Medical, Inc. Medical SpecialtiesHealth Technology The American company was founded by a practicing urologist with the aim of developing the preferred first-line device therapy for benign prostatic hyperplasia. The company's flagship product, the Flostent system, enables physicians to treat patients safely and efficiently, with minimal discomfort and reduced complications. Rivermark Medical plans to bring the Flostent system to market as their first product. The CEO of the company is Adam Kadlec. | Health Technology |